What are the diagnosis criteria for diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Diabetic Ketoacidosis (DKA)

DKA is diagnosed by the triad of hyperglycemia (blood glucose >250 mg/dL), metabolic acidosis (pH <7.3, serum bicarbonate <18 mEq/L), and elevated ketones in blood or urine. 1

Essential Diagnostic Criteria

  • Blood glucose >250 mg/dL (though euglycemic DKA with glucose <250 mg/dL can occur, especially with SGLT2 inhibitor use) 1, 2
  • Arterial pH <7.3 3, 1
  • Serum bicarbonate <18 mEq/L 3, 1
  • Positive serum and urine ketones 3, 1
  • Elevated anion gap >10-12 mEq/L 3
  • Mental status ranging from alert to coma depending on severity 3

Severity Classification

DKA can be classified into three severity levels based on arterial pH and serum bicarbonate 3:

  • Mild DKA:

    • Arterial pH: 7.25-7.30
    • Serum bicarbonate: 15-18 mEq/L
    • Mental status: Alert 3
  • Moderate DKA:

    • Arterial pH: 7.00-7.24
    • Serum bicarbonate: 10 to <15 mEq/L
    • Mental status: Alert/drowsy 3
  • Severe DKA:

    • Arterial pH: <7.00
    • Serum bicarbonate: <10 mEq/L
    • Mental status: Stupor/coma 3

Laboratory Evaluation

  • Essential tests for confirming DKA diagnosis:

    • Plasma glucose 1
    • Arterial blood gases for pH measurement 1
    • Serum bicarbonate 1
    • Serum ketones (preferably β-hydroxybutyrate) 1
    • Electrolytes with calculated anion gap 1
    • Urinalysis and urine ketones 1
    • Complete blood count with differential 1
    • Blood urea nitrogen/creatinine 1
  • β-hydroxybutyrate measurement is preferred over nitroprusside-based ketone tests for diagnosis and monitoring of DKA, as nitroprusside methods do not measure β-hydroxybutyrate, which is the predominant ketone in DKA 3, 1

Clinical Presentation

  • Common symptoms include polyuria, polydipsia, polyphagia, weight loss, vomiting, abdominal pain, dehydration, weakness, and altered mental status 3, 4
  • Physical findings may include poor skin turgor, Kussmaul respirations (deep, rapid breathing), tachycardia, hypotension, and potentially altered mental status 3, 1
  • DKA typically evolves rapidly (usually <24 hours) 3, 1
  • Up to 25% of DKA patients may present with emesis, which can be coffee-ground in appearance due to hemorrhagic gastritis 3

Special Considerations

  • Euglycemic DKA: Blood glucose <250 mg/dL with ketoacidosis can occur with:

    • SGLT2 inhibitor use 1, 5
    • Pregnancy 1, 2
    • Reduced food intake/starvation 1, 5
    • Alcohol use 1, 5
    • Liver disease 1, 2
  • Differential diagnosis for high anion gap metabolic acidosis includes:

    • Lactic acidosis 3, 1
    • Salicylate, methanol, ethylene glycol ingestion 3, 1
    • Alcoholic ketoacidosis (distinguished by clinical history and glucose levels rarely >250 mg/dL) 3, 1
    • Chronic renal failure 3

Common Precipitating Factors

  • Infection (most common) 3, 1
  • New-onset type 1 diabetes 3, 1
  • Insulin omission or inadequate insulin dosing 3, 1
  • Cerebrovascular accident 3, 1
  • Myocardial infarction 3, 1
  • Drug use (corticosteroids, thiazides, sympathomimetic agents) 3, 1
  • Alcohol abuse 3, 1
  • Pancreatitis 3, 1

Monitoring During Treatment

  • β-hydroxybutyrate levels should be used to monitor treatment response rather than nitroprusside-based ketone tests 3, 1
  • Resolution of acidosis or reduction in blood β-hydroxybutyrate is the marker for successful treatment 3, 1
  • Blood ketone determinations that rely on the nitroprusside reaction should not be used to monitor treatment of DKA 3

References

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Euglycemic Diabetic Ketoacidosis: A Review.

Current diabetes reviews, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Research

Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.

The American journal of emergency medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.